Patents/Assignees

Antagen Institute For Biomedical Research

1 patent in portfolio

US12559564utility2026
Compositions and Methods for Preventing or Reversing T-cell Exhaustion Through Ectonucleotidase Inhibition and Antibody-mediated Target Cytosis
0 cites